Newsfeeds - Spark Newswire

1 minute read

Earnings

Earnings Outlook For UroGen Pharma

Today, 8:14 PM

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate that UroGen Pharma will report an earnings per share (EPS) of $-1.17.

URGN

6 minute read

88 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:14 PM

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results.

AGRI

30 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 8:14 PM

During Tuesday's trading, 505 companies set new 52-week lows.

ACRX

19 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 8:14 PM

On Friday, 313 companies hit new 52-week lows.

AAON

10 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 8:14 PM

On Thursday, 147 companies achieved new lows for the year.

AFRM

1 minute read

HC Wainwright & Co. Maintains Buy on UroGen Pharma, Lowers Price Target to $34

By Benzinga Newsdesk

Today, 8:14 PM

HC Wainwright & Co. analyst Raghuram Selvaraju maintains UroGen Pharma (NASDAQ:URGN) with a Buy and lowers the price target from $50 to $34.

URGN

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 8:14 PM

During Friday's session, 445 companies made new 52-week lows.

AAOI

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 8:14 PM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

1 minute read

FDA
News

UroGen Pharma Sponsored Study Titled ‘Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC)’ Posted To ClinicalTrials.gov; Study Is Recruiting

By Benzinga Newsdesk

Today, 8:14 PM

https://clinicaltrials.gov/ct2/show/NCT05136898

URGN

4 minute read

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More

By Shanthi Rexaline

Today, 8:14 PM

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.

ACRX